Empower Advisory Group LLC Grows Stake in CVS Health Corporation $CVS

Empower Advisory Group LLC grew its holdings in shares of CVS Health Corporation (NYSE:CVS) by 90.9% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 12,387 shares of the pharmacy operator’s stock after buying an additional 5,897 shares during the period. Empower Advisory Group LLC’s holdings in CVS Health were worth $854,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CVS. Avion Wealth increased its position in CVS Health by 99.0% during the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 189 shares during the period. Harbor Asset Planning Inc. purchased a new position in shares of CVS Health during the second quarter valued at about $30,000. Bell Investment Advisors Inc lifted its holdings in CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after buying an additional 248 shares during the period. Roxbury Financial LLC boosted its position in CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 202 shares in the last quarter. Finally, ORG Partners LLC grew its holdings in shares of CVS Health by 418.9% during the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 377 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

CVS opened at $77.86 on Monday. The firm has a market cap of $98.84 billion, a PE ratio of 204.90, a P/E/G ratio of 0.87 and a beta of 0.60. The stock has a 50-day moving average price of $77.70 and a 200-day moving average price of $69.96. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $85.15. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.62.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. The business had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. CVS Health’s revenue was up 7.8% compared to the same quarter last year. During the same period last year, the business earned $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Sell-side analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 3rd. Investors of record on Thursday, October 23rd were given a $0.665 dividend. The ex-dividend date of this dividend was Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.4%. CVS Health’s dividend payout ratio is 700.00%.

Insider Buying and Selling

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the sale, the director directly owned 22,156 shares in the company, valued at approximately $1,573,519.12. This trade represents a 25.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.22% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on CVS shares. UBS Group raised their target price on CVS Health from $79.00 to $96.00 and gave the company a “buy” rating in a research note on Friday, October 24th. Cowen reissued a “buy” rating on shares of CVS Health in a research report on Monday, August 4th. Truist Financial reaffirmed a “buy” rating and issued a $95.00 target price (up from $92.00) on shares of CVS Health in a research report on Thursday, October 30th. Leerink Partners increased their price target on shares of CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a research note on Thursday, October 16th. Finally, Evercore ISI boosted their price objective on shares of CVS Health from $85.00 to $95.00 and gave the stock an “outperform” rating in a research note on Thursday, October 30th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $89.41.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.